• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对闭塞性冠状动脉疾病患者的综合心脏护理计划在降低死亡率方面的益处。

Mortality reduction benefits of a comprehensive cardiac care program for patients with occlusive coronary artery disease.

作者信息

Merenich John A, Olson Kari L, Delate Thomas, Rasmussen Jon, Helling Dennis K, Ward David G

机构信息

Department of Endocrinology, Colorado Permanente Medical Group, Denver, Colorado, USA.

出版信息

Pharmacotherapy. 2007 Oct;27(10):1370-8. doi: 10.1592/phco.27.10.1370.

DOI:10.1592/phco.27.10.1370
PMID:17896892
Abstract

STUDY OBJECTIVE

To determine the effect of early and sustained enrollment in a comprehensive cardiac care (CCC) program on all-cause mortality in patients with coronary artery disease (CAD).

DESIGN

Retrospective, longitudinal cohort study.

DATA SOURCE

Kaiser Permanente Colorado tracking database.

PATIENTS

A total of 4896 patients with an incident occlusive CAD event (index event), defined as acute myocardial infarction and/or percutaneous coronary intervention with or without stent placement, between January 1, 1996 and June 30, 2004.

MEASUREMENTS AND MAIN RESULTS

All patients were categorized into one of four cohorts by time to enrollment into the CCC program relative to the index event: early CCC-enrolled less than 90 days after the index event (1630 patients), delayed CCC--enrolled 90 days or more after the index event (1211 patients), intermittent CCC--enrolled intermittently with noncontinuous care (483 patients), and no CCC--never enrolled (1572 patients). The primary outcome was all-cause mortality. Patients were censored at death from all causes, end of health plan membership, or study end (December 31, 2005), whichever came first. Patients with any exposure to the CCC were less likely to die compared with the no CCC cohort (p<0.001). After adjusting for baseline covariates, the early, delayed, and intermittent CCC cohorts had reduced hazard rate ratios for all-cause mortality of 0.11 (95% confidence interval [CI] 0.08-0.14), 0.35 (95% CI 0.29-0.44), and 0.54 (95% CI 0.41-0.70), respectively, compared with the no CCC cohort (all p<0.001).

CONCLUSIONS

Compared with those not enrolled in the CCC program, patients enrolled in the early CCC were 89% less likely to die. The earlier the program is started after a coronary event, the better the mortality reduction benefit.

摘要

研究目的

确定早期持续加入综合心脏护理(CCC)项目对冠心病(CAD)患者全因死亡率的影响。

设计

回顾性纵向队列研究。

数据来源

科罗拉多州凯撒医疗机构追踪数据库。

患者

1996年1月1日至2004年6月30日期间,共有4896例发生闭塞性CAD事件(索引事件)的患者,该事件定义为急性心肌梗死和/或有或无支架置入的经皮冠状动脉介入治疗。

测量指标及主要结果

根据相对于索引事件加入CCC项目的时间,将所有患者分为四个队列之一:早期加入CCC(索引事件后不到90天,1630例患者)、延迟加入CCC(索引事件后90天或更长时间,1211例患者)、间歇性加入CCC(间歇性接受非连续性护理,483例患者)和未加入CCC(从未加入,1572例患者)。主要结局是全因死亡率。患者在因任何原因死亡、健康计划成员资格结束或研究结束(2005年12月31日)时被截尾,以先发生者为准。与未加入CCC队列相比,任何接触过CCC的患者死亡可能性均较低(p<0.001)。在对基线协变量进行调整后,与未加入CCC队列相比,早期、延迟和间歇性加入CCC队列的全因死亡率风险比分别降低了0.11(95%置信区间[CI]0.08-0.14)、0.35(95%CI 0.29-0.44)和0.54(95%CI 0.41-0.70)(所有p<0.001)。

结论

与未加入CCC项目的患者相比,早期加入CCC的患者死亡可能性降低了89%。冠状动脉事件后项目启动越早,降低死亡率的益处就越大。

相似文献

1
Mortality reduction benefits of a comprehensive cardiac care program for patients with occlusive coronary artery disease.针对闭塞性冠状动脉疾病患者的综合心脏护理计划在降低死亡率方面的益处。
Pharmacotherapy. 2007 Oct;27(10):1370-8. doi: 10.1592/phco.27.10.1370.
2
Outcomes of patients discharged from pharmacy-managed cardiovascular disease management.从药学管理的心血管疾病管理中出院的患者的结局。
Am J Manag Care. 2009 Aug;15(8):497-503.
3
Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease.药物洗脱支架植入经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗多支冠状动脉疾病后的长期死亡率。
Circulation. 2008 Apr 22;117(16):2079-86. doi: 10.1161/CIRCULATIONAHA.107.750109. Epub 2008 Apr 14.
4
Factors associated with recurrent coronary events among patients with cardiovascular disease.
Pharmacotherapy. 2009 Aug;29(8):906-13. doi: 10.1592/phco.29.8.906.
5
Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes.药物洗脱支架与裸金属支架治疗急性冠状动脉综合征中无保护左主干冠状动脉疾病的比较。
Am J Cardiol. 2009 Jan 15;103(2):187-93. doi: 10.1016/j.amjcard.2008.08.059. Epub 2008 Oct 30.
6
Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a single integrated health network.急性心肌梗死住院或支架植入术后早期停用氯吡格雷的临床影响:在单一综合健康网络中的分析
Curr Med Res Opin. 2009 Sep;25(9):2317-25. doi: 10.1185/03007990903156061.
7
Lipid management in patients with coronary artery disease by a clinical pharmacy service in a group model health maintenance organization.在一个团体模式健康维护组织中,通过临床药学服务对冠心病患者进行血脂管理。
Arch Intern Med. 2005 Jan 10;165(1):49-54. doi: 10.1001/archinte.165.1.49.
8
Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.在常规临床实践中,与其他他汀类药物相比,瑞舒伐他汀治疗的老年患者的低密度脂蛋白胆固醇(LDL-C)水平及LDL-C达标情况。
Am J Geriatr Pharmacother. 2007 Sep;5(3):185-94. doi: 10.1016/j.amjopharm.2007.10.002.
9
Improving long-term outcomes following coronary artery bypass graft or percutaneous coronary revascularisation: results from a large, population-based cohort with first intervention 1995-2004.改善冠状动脉搭桥术或经皮冠状动脉血运重建术后的长期预后:来自一个基于人群的大型队列研究的结果,首次干预时间为1995 - 2004年。
Heart. 2009 Feb;95(4):304-11. doi: 10.1136/hrt.2007.127928. Epub 2008 Nov 10.
10
Obesity paradox in patients with hypertension and coronary artery disease.高血压和冠状动脉疾病患者中的肥胖悖论
Am J Med. 2007 Oct;120(10):863-70. doi: 10.1016/j.amjmed.2007.05.011.

引用本文的文献

1
Closing the Gaps in Care of Dyslipidemia: Revolutionizing Management with Digital Health and Innovative Care Models.缩小血脂异常治疗差距:借助数字健康和创新护理模式变革管理方式
Rev Cardiovasc Med. 2023 Dec 13;24(12):350. doi: 10.31083/j.rcm2412350. eCollection 2023 Dec.
2
A cluster randomized trial to evaluate a centralized remote clinical pharmacy service in large, health system primary care clinics.一项集群随机试验,旨在评估大型医疗系统基层医疗诊所中的集中式远程临床药学服务。
J Am Coll Clin Pharm. 2021 Oct;4(10):1287-1299. doi: 10.1002/jac5.1497. Epub 2021 Jul 2.
3
Development of a centralized, remote clinical pharmacy service to enhance primary care.
开发集中式远程临床药学服务以加强初级保健。
Pharm Pract (Granada). 2021 Jan-Mar;19(1):2348. doi: 10.18549/PharmPract.2021.1.2348. Epub 2021 Mar 10.
4
Trends in high intensity statin use among secondary prevention patients 76 years and older.76岁及以上二级预防患者高强度他汀类药物使用趋势。
Pharm Pract (Granada). 2019 Apr-Jun;17(2):1402. doi: 10.18549/PharmPract.2019.2.1402. Epub 2019 May 29.
5
Evaluation of Interventions by Clinical Pharmacy Specialists in Cardiology at a VA Ambulatory Cardiology Clinic.退伍军人事务部门诊心脏病诊所的临床药学专家对干预措施的评估。
Fed Pract. 2019 Feb;36(2):56-62.
6
Evolution of Clinical Pharmacy in the USA and Future Directions for Patient Care.美国临床药学的发展历程及患者护理的未来方向。
Drugs Aging. 2016 Mar;33(3):169-77. doi: 10.1007/s40266-016-0349-2.
7
A Cluster-Randomized Trial of a Centralized Clinical Pharmacy Cardiovascular Risk Service to Improve Guideline Adherence.一项关于集中式临床药学心血管风险服务以提高指南依从性的整群随机试验。
Pharmacotherapy. 2015 Jul;35(7):653-62. doi: 10.1002/phar.1603. Epub 2015 Jun 25.
8
A centralized cardiovascular risk service to improve guideline adherence in private primary care offices.一项旨在提高私立初级保健诊所指南依从性的集中式心血管风险服务。
Contemp Clin Trials. 2015 Jul;43:25-32. doi: 10.1016/j.cct.2015.04.014. Epub 2015 May 4.
9
Comparative health systems research among Kaiser Permanente and other integrated delivery systems: a systematic literature review.凯撒医疗集团与其他整合式医疗服务体系的比较卫生系统研究:一项系统文献综述
Perm J. 2014 Summer;18(3):66-77. doi: 10.7812/TPP/13-159. Epub 2014 Jun 9.
10
Ambulatory treatment gaps in patients with ischemic stroke or transient ischemic attack.缺血性中风或短暂性脑缺血发作患者的门诊治疗差距。
Perm J. 2013 Summer;17(3):28-34. doi: 10.7812/TPP/12-145.